Physician Assistant · Oceanside, CA
NPI
1912266883
Since 2012
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3613 Vista Way
Oceanside, CA, 92056
Phone (760) 758-5340
Groups this clinician bills Medicare through
Medicare paid, 2024
$292K
10,164 services
Medicare patients, 2024
822
Average age 76
Drug cost, 2024
$399K
848 prescriptions
Company payments, 2025
$1,857
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mitzi Bray was code J7345 (aminolevulinic acid hcl for topical administration, 10% gel, 10 mg), 4,400 times for 20 patients. In total Mitzi Bray billed 10,164 services in 53 codes, and Medicare paid $292K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-05-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 4,400 | 20 | $1.35 | $5,923 |
| 17003 Destruction Skin Lesion | Office | 1,847 | 272 | $5.16 | $9,538 |
| 99213 Office E&M - Established | Office | 722 | 454 | $62.39 | $45K |
| 99214 Office E&M - Established | Office | 662 | 396 | $87.70 | $58K |
| 17000 Destruction Skin Lesion | Office | 465 | 338 | $35.19 | $16K |
| 11102 Skin Biopsy | Office | 443 | 350 | $66.84 | $30K |
| 17110 Destruction Skin Lesion | Office | 356 | 268 | $79.47 | $28K |
| 11103 Skin Biopsy | Office | 200 | 121 | $39.97 | $7,993 |
| 17004 Destruction Skin Lesion | Office | 101 | 75 | $118.10 | $12K |
| 12032 Wound Repair - All Levels | Office | 95 | 81 | $237.53 | $23K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 91 | 50 | $0.74 | $66.89 |
| 99212 Office E&M - Established | Office | 90 | 86 | $35.84 | $3,226 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 83 | 61 | $12.25 | $1,017 |
| 11602 Skin Lesion Excision | Office | 81 | 66 | $98.00 | $7,938 |
| 11900 Skin | Office | 53 | 41 | $34.60 | $1,834 |
By year: 2022 $164K for 3,915 services; 2023 $226K for 6,113 services; 2024 $292K for 10,164 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| Q0112 All potassium hydroxide (koh) preparations | 14 | 14 | $5.71 | $79.94 |
Medicare prescription drug claims, 2024
In 2024, the drug Mitzi Bray prescribed most often to Medicare patients was Triamcinolone Acetonide, with 123 prescriptions and refills. In total Mitzi Bray wrote 848 Medicare prescriptions that cost $399K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 123 | 127 | 100 | $661 |
| Fluorouracil Generic | 84 | 88 | 72 | $4,955 |
| Ketoconazole Generic | 69 | 73 | 40 | $1,179 |
| Clobetasol Propionate Generic | 66 | 68 | 46 | $2,972 |
| Mupirocin Generic | 48 | 48 | 43 | $410 |
| Spironolactone Generic | 46 | 75 | 11 | $197 |
| Doxycycline Hyclate Generic | 33 | 33 | 25 | $332 |
| Valacyclovir Valacyclovir Hcl | 32 | 38 | 19 | $607 |
| Metronidazole Generic | 29 | 31 | 18 | $1,243 |
| Minoxidil Generic | 25 | 49 | Under 11 | $106 |
| Imiquimod Generic | 22 | 24 | Under 11 | $336 |
| Ciclopirox Generic | 21 | 21 | Under 11 | $763 |
| Clindamycin Phosphate Generic | 18 | 24 | Under 11 | $642 |
| Cosentyx Sensoready (2 Pens) Secukinumab | 18 | 18 | Under 11 | $130K |
| Doxycycline Monohydrate Generic | 16 | 20 | Under 11 | $600 |
Brand drugs: 91 claims; generic drugs: 757 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mitzi Bray $1,857 ($1,857 in general payments such as food, travel and fees) from 19 companies. The largest payer was Janssen Biotech, Inc. with $264.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 18 | $264 |
| Abbvie Inc. ABBV | 13 | $225 |
| Arcutis Biotherapeutics, Inc. ARQT | 10 | $203 |
| Galderma Laboratories, L.P. GALD.SW | 9 | $155 |
| Incyte Corporation INCY | 6 | $146 |
| LEO Pharma Inc. | 8 | $144 |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $139 |
| Pfizer Inc. PFE | 5 | $85.62 |
| UCB, Inc. UCB.BR | 4 | $76.89 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $70.13 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.